Stratpharma are leading the market with breakthrough treatments for post procedure care, scar management and stretch mark prevention.
Fast becoming Australia’s most trusted provider of solutions for wound healing and scar therapy, Swiss company Stratpharma has taken the market by storm with their gel-based products, Stratamed, Strataderm and StrataXRT.
The Swiss-based company has recently added Stratamark, for the prevention and treatment of stretch marks, to their impressive product line.
Stratpharma has earned the trust of Australia’s leading cosmetic medical practitioners, including dermatologists, plastic surgeons, cosmetic surgeons and physicians, and ENT and facial plastic surgeons.
Providing groundbreaking treatments following major cosmetic surgery such as breast augmentation or facial plastic surgery, minor surgical procedures, or the prevention and treatment of stretch marks, the Stratpharma suite of products has become an essential and pivotal part of wound healing, scar management and stretch mark treatment and prevention protocols.
Stratamed – gel wound dressing
In terms of patient satisfaction, wound healing and scar management are critical components following major cosmetic surgery, such as breast augmentation or facial plastic surgery, post-laser therapy or after undergoing radiotherapy and relatively minor procedures such as skin cancer removal.
Stratamed is the first gel formula that can be used on open wounds and compromised skin surfaces. Its advanced flexible film-forming wound dressing provides faster wound healing and prevents abnormal scar formation.
Stratamed is bacteriostatic, gas permeable and inert. It can be applied immediately after surgery or skin resurfacing to promote faster re-epithelialisation and a reduced inflammatory response.
Strataderm – scar therapy gel
Strataderm prevents and treats new and old hypertrophic scars and keloids. It is internationally renowned as the gold standard in non-invasive scar treatment, and can be used either as monotherapy or in combination with more invasive therapy.
For existing scars, the gel helps to soften and flatten raised scars, reduce redness and discolourisation, and relieve the itching and discomfort that can be associated with scars.
Strataderm is popular with both doctors and patients alike. Doctors generally prefer the gel to silicone sheets and patients find the gel simple and easy to use, leading to better compliance.
StrataXRT – radiation dermatitis prevention & treatment
StrataXRT is used to relieve low- grade inflammatory changes such as dryness, itching, flaking, peeling and irritated skin. For more severe inflammatory changes, StrataXRT reduces pain, redness and heat and helps soothe the exposed skin areas.
StrataXRT is a tube-dispensed, self-drying, occlusive topical gel developed from advances in polymer technology. This product was specifically developed for usage before and after radiation therapy and is mainly used in radiation oncology.
It is (with the exception of Stratamed) the only self-drying silicone device, which has been approved for use on open wounds and compromised skin.
Unlike most radiation dermatitis treatments, StrataXRT is registered as a medical device with European CE mark and is a class 1 wound dressing listed with the US FDA.
It is also an extremely economical alternative to other products on the market for this indication.
A novel use of StrataXRT that is rapidly gaining traction is on immediate post-laser skin.
StrataXRT is suitable for use after laser skin resurfacing and is fast becoming a key product, nurturing the skin and allowing it to breathe post-treatment.
For the patient, it is pleasant and doesn’t sting and unlike many other products used post-surgery, it is not uncomfortable or sticky after application.
By helping to promote a moist wound-healing environment for widespread superficial wounds and burns, StrataXRT promotes faster re-epithelialisation and significantly reduces the skin’s acute inflammatory response.
It is being shown to improve healing time dramatically, helping to prevent infection by building a protective barrier. Normally applied on the patient straight after treatment, within about two days StrataXRT reduces inflammation and redness.
StrataXRT may also be used in conjunction with other adjunctive treatments to improve overall results and can be used with or without a secondary protective dressing for a minimum of 60-90 days (24/7) post radiation therapy or until no further improvement is seen.
StrataXRT can be used in several indications, including on post-laser tattoo removal. It minimises any skin irritation and prevents side effects such as blistering if used effectively and continued by the patient. One of the benefits of this product is that it doesn’t contain alcohol and can be used on patients who are allergic to alcohol-based creams.
Stratamark – stretch mark prevention & treatment
Stratamark is the first clinically proven topical medical device for stretch marks, backed by clinical trials and TGA approval.
Stratamark, the innovative new addition to the Stratpharma range, hydrates and protects the skin, forming a thin, flexible and protective gel sheet that is gas permeable and hydrophobic, allowing the skin to normalise the collagen synthesis cycle to efficiently treat and prevent stretch marks.
The unique gel formula influences an epidermal-dermal signalling cascade via a regulatory role of the epidermis on fibroblast production. Keratinocytes have been shown to activate the fibroblasts, hence collagen and glycosaminoglycan production. This leads to the normalising of the keratinocyte hydration status and the normalising of tissue growth factors, which signals dermal fibroblasts to normalise the collagen synthesis cycle of stretch marks.
Stiae distensae, or stretch marks, are a form of abnormal scarring in which the dermal collagen ruptures and separates. Both men and women can have stretch marks due to growth spurts, for example during puberty, rapid weight gain or steroid use, in addition to pregnancy.
Unlike cosmetic and moisturising products, Stratamark is a medical device for the prevention and treatment of stretch marks. It is applied once daily as a thin layer directly to clean, dry skin. Drying within a few minutes, it can be covered by garments, cosmetics or sunscreen.
For prevention of stretch marks in pregnant women, Stratamark application is recommended from the beginning of the second trimester until 60 to 90 days post partum.
For treatment of existing stretch marks, 60 to 90 days of continuous usage is recommended until no further improvement is seen. Stratamark needs to be in constant contact with the skin 24/7.
It can also be used alone or in combination with other stretch mark treatment including laser therapy.
A novel treatment for breast augmentation stretch mark prevention
A novel use of Stratamark is in its application before and after breast augmentation surgery. Applying Stratamark pre and post breast surgery is showing efficacy in preventing stretch marks from developing after implant surgery.
Not all breast augmentation patients will develop stretch marks; but for those that do, it can mar the result and be a source of ongoing dissatisfaction.
Stretch marks after breast implant surgery are most common when too large an implant is chosen for the patient’s chest dimensions. Other risk factors include predisposition (stretch marks elsewhere on the body) and poor skin elasticity and overall skin quality.
Stratamark helps to hydrate the skin and normalise the collagen synthesis cycle – and protect the skin against dermal tearing after rapid expansion or stretching of the skin such as after insertion of breast implants.
Stratamark should be used each day as part of pre-op preparation, and for an additional 60 to 90 days post surgery.
For more information or to trial Stratamark call 1800 567 007 or visit www.stratamark.net